Patent details
LUC00315 Product Name: Ivosidenib or a pharmaceutically acceptable salt, tautomer, isotopologue or hydrate thereof
Basic Information
- Publication number:
- LUC00315
- Type:
- SPC
- SPC Type:
- Medical
- Basic Patent Number:
- EP137383196
- Legal Status:
- Pending & Published
- Application number:
- LUC00315
- First applicant's nationality:
- Procedural language:
- French
Marketing Authorization
- Marketing Authorization Number:
- EU/1/23/1728
- Marketing Authorization Type:
- Marketing Authorization Date:
- 08/05/2023
- Marketing Authorization Status:
- Accepted
- Marketing Authorization Country:
- Luxembourg (LU)
Dates
- Filing date:
- 17/09/2023
- First Marketing Authorization date:
- 08/05/2023
- Grant date:
- Activation date:
- Publication date:
- 18/09/2023
- Lapsed date:
- Expiration date:
- Renunciation date:
- Revocation date:
- Annulment date:
- Basic SPC Expiration:
- 21/01/2038
- SPC Extension Expiration:
- 21/01/2038
- Rejection date:
- Withdrawal date:
Owner
- From:
- 17/09/2023
- Name:
- LES LABORATOIRES SERVIER
- Address:
- 50, rue Carnot, 92284, Suresnes Cedex, France (FR)
Agent
- Name:
- Dennemeyer & Associates S.A.
- From:
- 17/09/2023
- Address:
- 55, rue des Bruyères, L-1274, HOWALD, Luxembourg (LU)
- To:
Publication
Bulletin
- Bulletin Heading:
- SPC1
- Bulletin edition number:
- 2023/11
- Publication date:
- 05/10/2023
- Description:
- Section C : Published requests for Supplementary Protection Certificates – I1 publication
Annual Fees
- Annual Fee Due Date:
- 31/01/2033
- Annual Fee Number:
- 21
- Annual Fee Amount:
- 410 Euro
- Expected Payer:
- Last Annual Fee Payment Date:
- Last Annual Fee Paid Number:
- Payer:
| Filing date | Document type | Number of pages |
|---|---|---|
| 17/09/2023 | Application Form | 5 |
| 17/09/2023 | Marketing authorization | 3 |
| 17/09/2023 | Summary of the product caracteristics | 42 |
| 17/09/2023 | MA publication | 10 |
| 17/09/2023 | General Document | 68 |
| 18/09/2023 | Outgoing Correspondence | 1 |
| 18/09/2023 | Publication | 1 |